Cargando…
Inhibitory effect of a new orally active cedrol-loaded nanostructured lipid carrier on compound 48/80-induced mast cell degranulation and anaphylactic shock in mice
BACKGROUND: Type I hypersensitivity is an allergic reaction characterized by the overactivity of the immune system provoked by normally harmless substances. Glucocorticoids, anti-histamines, or mast cell stabilizers are the choices of treatment for type I hypersensitivity. Even though these drugs ha...
Autores principales: | Chakraborty, Shreyasi, Kar, Nabanita, Kumari, Leena, De, Asit, Bera, Tanmoy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511028/ https://www.ncbi.nlm.nih.gov/pubmed/28744120 http://dx.doi.org/10.2147/IJN.S132114 |
Ejemplares similares
-
The Mast Cell Degranulator Compound 48/80 Directly Activates Neurons
por: Schemann, Michael, et al.
Publicado: (2012) -
Anaphylactic Degranulation of Mast Cells: Focus on Compound Exocytosis
por: Klein, Ofir, et al.
Publicado: (2019) -
Corilagin Attenuates Allergy and Anaphylactic Reaction by Inhibiting Degranulation of Mast Cells
por: Zhou, Jie, et al.
Publicado: (2018) -
Formononetin Inhibits Mast Cell Degranulation to Ameliorate Compound 48/80-Induced Pseudoallergic Reactions
por: Zhou, Zi-Wen, et al.
Publicado: (2023) -
NAD(+)-boosting molecules suppress mast cell degranulation and anaphylactic responses in mice
por: Kim, Hyun-Woo, et al.
Publicado: (2022)